Bioaccessibility of the new dipeptide nootropic drug noopept

被引：0
|
作者：
S. S. Boiko
V. P. Zherdev
T. A. Gudasheva
R. U. Ostrovskaya
S. A. Korotkov
O. Yu. Kravtsova
机构：
[1] Russian Academy of Medical Sciences,Zakusov Institute of Pharmacology
来源：
Pharmaceutical Chemistry Journal | 2004年 / 38卷 / 12期
关键词：
Organic Chemistry; Dipeptide; Nootropic Drug;
D O I：
10.1007/s11094-005-0050-y
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：645 / 647
页数：2
相关论文
共 50 条
  • [21] Prolyl-containing dipeptide Noopept-potential therapeutics of Alzheimer disease
    Ostrovskaya, Rita
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 372 - 372
  • [22] Molecular Mechanism Underlying the Action of Substituted Pro-Gly Dipeptide Noopept
    Vakhitova, Y. V.
    Sadovnikov, S. V.
    Borisevich, S. S.
    Ostrovskaya, R. U.
    Gudasheva, T. A.
    Seredenin, S. B.
    ACTA NATURAE, 2016, 8 (01): : 82 - 89
  • [23] A SURVEY OF THE AVAILABLE DATA ON A NEW NOOTROPIC DRUG, BCE-001
    ZSNAGY, I
    PHARMACOLOGY OF AGING PROCESSES: METHODS OF ASSESSMENT AND POTENTIAL INTERVENTIONS, 1994, 717 : 102 - 114
  • [24] RETRACTED: Noopept; a nootropic dipeptide, modulates persistent inflammation by effecting spinal microglia dependent Brain Derived Neurotropic Factor (BDNF) and pro-BDNF expression throughout apoptotic process (Retracted Article)
    Taghizadeh, Mona
    Maghsoudi, Nader
    Manaheji, Homa
    Akparov, Valery
    Baniasadi, Mansoureh
    Mohammadi, Mola
    Danyali, Samira
    Ghasemi, Rasoul
    Zaringhalam, Jalal
    HELIYON, 2021, 7 (02)
  • [25] The effect of the synthetic neuroprotective dipeptide Noopept on glutamate release from rat brain cortex slices
    Us, K. S.
    Klodt, P. M.
    Kudrin, V. S.
    Sapronova, A. Ya.
    Ostrovskaya, R. U.
    Ugryumov, M. V.
    Rayevsky, K. S.
    NEUROCHEMICAL JOURNAL, 2007, 1 (02) : 138 - 142
  • [26] To the endogenous peptidergic mechanism involvement in the action of the nootropic dipeptide, GVS-111.
    Seredenin, SB
    Gudasheva, TA
    Ostrovskaya, RU
    Bojko, SS
    Akparov, V
    Diamond, G
    Voronina, TA
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R713 - R713
  • [27] PHARMACOKINETICS OF THE NOOTROPIC DRUG OXIRACETAM IN THE ELDERLY
    PERUCCA, E
    ALBRICI, A
    PARINI, J
    VISCONTI, M
    FERRERO, E
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (04) : P577 - P578
  • [28] Neuroprotective effect of proline-containing dipeptide, noopept on PC12 neuronal cells
    Salimgareeva, M. K.
    Fatkullina, U. S.
    Zainullina, L. F.
    Vakhitova, J. V.
    Ostrovskaya, R. U.
    Seredenin, S. B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S155 - S156
  • [29] Pharmacokinetics of the potential nootropic drug of 6145
    V. L. Dorofeev
    V. V. Chistyakov
    A. P. Arzamastsev
    Pharmaceutical Chemistry Journal, 1997, 31 (11) : 565 - 567
  • [30] CLINICAL USE OF PIRACETAM, A NEW NOOTROPIC DRUG - TREATMENT OF SYMPTOMS OF SENILE INVOLUTION
    STEGINK, AJ
    ARZNEIMITTEL-FORSCHUNG, 1972, 22 (06): : 975 - &
12345